Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses

Trends Immunol. 2022 Aug;43(8):617-629. doi: 10.1016/j.it.2022.06.001. Epub 2022 Jul 8.

Abstract

Despite antiretroviral therapy (ART), HIV-1 persists as proviruses integrated into the genomic DNA of CD4+ T cells. The mechanisms underlying the persistence and clonal expansion of these cells remain incompletely understood. Cases have been described in which proviral integration can alter host gene expression to drive cellular proliferation. Here, we review observations from other genome-integrating human viruses to propose additional putative modalities by which HIV-1 integration may alter cellular function to favor persistence, such as by altering susceptibility to cytotoxicity in virus-expressing cells. We propose that signals implicating such mechanisms may have been masked thus far by the preponderance of defective and/or nonreactivatable HIV-1 proviruses, but could be revealed by focusing on the integration sites of intact proviruses with expression potential.

Keywords: host–virus DNA interactions; insertional mutagenesis; virus integration; virus-induced cell proliferation; virus–host chimeric RNA.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • CD4-Positive T-Lymphocytes
  • HIV Infections* / drug therapy
  • HIV-1*
  • Humans
  • Proviruses / genetics
  • Virus Integration

Substances

  • Anti-Retroviral Agents